OneMedNet Reports Over 25% Expansion of iRWD™ Network, Encompassing Clinical Data alongside Aggregate Health Economics and Social Determinant Insights from 5 Billion Administrative Records, Fueling Growth in AI-Powered Healthcare Data

Rhea-AI Summary

OneMedNet (NASDAQ:ONMD), a leader in AI-powered Real-World Data (RWD), has announced a 25% expansion of its iRWD™ network and platform. The company now encompasses 1,750+ healthcare system partner sites, providing access to 34 million patients, 136 million clinical exams, and 5 billion administrative records.

The expansion significantly enhances OneMedNet's capability to provide insights into rare diseases, underserved populations, and health economics. Operating in the $60 billion RWE industry, the company is positioned for accelerated revenue growth through increased data licensing and new enterprise partnerships.

Positive

• 25% expansion of iRWD™ network reaching 1,750+ healthcare system sites
• Massive data scale with 136 million clinical exams and 5 billion administrative records
• Enhanced coverage of rare diseases and underserved populations
• Strong positioning in the $60 billion RWE industry

Negative

• None.

Insights

Healthcare Data Analytics Expert

OneMedNet's 25% network expansion significantly enhances its real-world data capabilities, strengthening its competitive position in the growing $60B RWE market.

OneMedNet has achieved a substantial 25% expansion of its iRWD™ network, demonstrating impressive growth in its real-world data infrastructure. The expanded network now encompasses over 1,750 healthcare provider sites, providing access to data from 34 million patients and 136 million clinical exams. Most notably, the company has incorporated 5 billion administrative records that include critical health economics and social determinants of health information.

This expansion directly addresses several high-value market needs: longitudinal patient data, rare disease insights, and comprehensive datasets that include both clinical and economic factors. By incorporating data from underserved populations, OneMedNet is positioning itself to serve researchers focused on health equity – an increasingly important area in healthcare analytics.

From a business perspective, this network expansion creates multiple revenue acceleration opportunities. The substantially larger data pool enhances OneMedNet's value proposition to life sciences companies, payers, and healthcare innovators who rely on real-world evidence for research, development, and strategic decision-making. The timing is particularly advantageous as OneMedNet reports the RWE industry is valued at approximately $60 billion.

The combination of clinical depth and administrative breadth differentiates OneMedNet in the competitive healthcare data market. While many competitors offer either clinical or administrative data, OneMedNet's integrated approach provides a more comprehensive view of patient journeys, treatment patterns, and outcomes – exactly the type of multi-dimensional data that commands premium pricing in today's market.

This expansion represents not just incremental growth but a strategic positioning that could translate to accelerated revenue through both expanded data licensing opportunities and new enterprise partnerships, potentially establishing OneMedNet as a more significant player in the rapidly evolving healthcare data analytics landscape.

Over 1,750 provider sites and access to 136 million clinical exams positions OneMedNet for accelerated revenue and market penetration

MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced today a greater than 25% expansion of its proprietary iRWD™ network and platform, underscoring the Company’s strategic execution and market responsiveness. This milestone significantly enhances the Company's reach, operational capacity, and growth trajectory – including the addition of over 5 billion administrative records that support aggregated health economics research and insights into social determinants of health.

Driven by the rising demand for high-quality longitudinal data, rare disease insights, and datasets that include health economics and social determinants of health, OneMedNet has rapidly accelerated the development of new partner sites across its nationwide network. This expansion also responds to the growing need for inclusive data representing underserved and underrepresented populations.

As a result, OneMedNet now provides its customers with seamless access to a dramatically scaled, de-identified data network comprising the following key growth metrics:

• 25% iRWD™ network expansion
• 1750+ healthcare system and provider partner sites
• 34 million patients
• 136 million clinical exams
• 5 billion Administrative Records, inclusive of claims
• Addresses rare diseases, underserved populations, and high-demand RWD sectors by enabling insights into health economic and social determinants
• Poised for significant revenue growth through increased data licensing and new enterprise partnerships
  

This exponential growth not only reinforces OneMedNet’s position as a premier data partner but also lays the foundation for accelerated revenue generation, customer acquisition, and data monetization at scale.

At OneMedNet, we believe Real-World Evidence is only as powerful as the clinical integrity of the data behind it. The OneMedNet iRWD™ network and platform delivers regulatory-grade depth and precision, enabling life sciences, payers, and healthcare innovators to generate clinically grounded insights that are actionable and reflective of how care is delivered in the real world. As the $60 billion RWE industry¹, continues to transform, OneMedNet is proud to be at the forefront, helping make evidence generation faster, more effective, and more grounded in real clinical reality says Aaron Green, President & CEO, OneMedNet.

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

FAQ

What is the size of OneMedNet's (ONMD) iRWD™ network after the recent expansion?

After the recent 25% expansion, OneMedNet's network includes 1,750+ healthcare system partner sites, covering 34 million patients and 136 million clinical exams.

How many administrative records does OneMedNet (ONMD) now have access to?

OneMedNet now has access to 5 billion administrative records that support aggregated health economics research and insights into social determinants of health.

What is the market size for Real-World Evidence (RWE) industry where OneMedNet operates?

OneMedNet operates in the $60 billion Real-World Evidence (RWE) industry.

How does OneMedNet's expansion impact its revenue potential?

The expansion positions OneMedNet for accelerated revenue growth through increased data licensing opportunities and new enterprise partnerships.

What types of healthcare data does OneMedNet's iRWD™ network provide?

OneMedNet's network provides access to clinical exams, administrative records, rare disease data, health economics information, and insights into social determinants of health, particularly focusing on underserved populations.